Additive effects of glucagon-like peptide 1 and pioglitazone in patients with type 2 diabetes.

Pharmacology, Toxicology and Pharmaceutical Science

• Pioglitazone 100%
• Non Insulin Dependent Diabetes Mellitus 100%
• Glucagon-Like Peptide-1 100%
• Monotherapy 60%
• Combination Therapy 50%
• Table Salt 30%
• Fatty Acid 20%
• Glucagon 20%
• Subcutaneous Injection 10%
• Tablet 10%

Keyphrases

• Actos 10%
• Therapeutic Approaches 10%